Clinical Trial: Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of A

Brief Summary: The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.

Detailed Summary:
Sponsor: CollaGenex Pharmaceuticals

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: CollaGenex Pharmaceuticals

Dates:
Date Received: July 19, 2002
Date Started: June 2002
Date Completion:
Last Updated: June 23, 2005
Last Verified: November 2003